Contact Boehringer Ingelheim’s Business Development and Licensing team to explore partnering opportunities

Submit your partnership inquiry to see how we can work together across the pharmaceutical industry to drive innovative treatments forward for patients.

Please fill out this form to get in touch with someone from our Business Development and Licensing team.

Contact Details

• First name: Required.

• Last name: Required.

• Job title:

• Email: Required.

• Phone:

• Company / organization: Required.

• Country:

  • Select
  • Afghanistan
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antarctica
  • Antigua & Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Ascension Island
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia & Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Canary Islands
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Ceuta & Melilla
  • Chad
  • Chile
  • China
  • Christmas Island
  • Clipperton Island
  • Cocos (Keeling) Islands
  • Colombia
  • Comoros
  • Congo - Brazzaville
  • Congo - Kinshasa
  • Cook Islands
  • Costa Rica
  • Croatia
  • Cuba
  • Curaçao
  • Cyprus
  • Czechia
  • Côte d’Ivoire
  • Denmark
  • Diego Garcia
  • Djibouti
  • Dominica
  • Dominican Republic
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Eswatini
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard & McDonald Islands
  • Honduras
  • Hong Kong SAR China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jersey
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao SAR China
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar (Burma)
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • North Korea
  • North Macedonia
  • Norway
  • Oman
  • Outlying Oceania
  • Pakistan
  • Palau
  • Palestinian Territories
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Romania
  • Russia
  • Rwanda
  • Réunion
  • Samoa
  • San Marino
  • Sark
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia & South Sandwich Islands
  • South Korea
  • South Sudan
  • Spain
  • Sri Lanka
  • St. Barthélemy
  • St. Helena
  • St. Kitts & Nevis
  • St. Lucia
  • St. Martin
  • St. Pierre & Miquelon
  • St. Vincent & Grenadines
  • Sudan
  • Suriname
  • Svalbard & Jan Mayen
  • Sweden
  • Switzerland
  • Syria
  • São Tomé & Príncipe
  • Taiwan
  • Tajikistan
  • Tanzania
  • Thailand
  • Timor-Leste
  • Togo
  • Tokelau
  • Tonga
  • Trinidad & Tobago
  • Tristan da Cunha
  • Tunisia
  • Turkmenistan
  • Turks & Caicos Islands
  • Tuvalu
  • Türkiye
  • U.S. Outlying Islands
  • U.S. Virgin Islands
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican City
  • Venezuela
  • Vietnam
  • Wallis & Futuna
  • Western Sahara
  • Yemen
  • Zambia
  • Zimbabwe
  • Åland Islands

• Website:

• Describe your opportunity:

• Opportunity title: Required.

• Asset or technology name: Required.

• Latest development phase: Required.

  • Select
  • Pre-clinical
  • Phase 1
  • Phase 2

• Therapeutic or technology area: Required.

  • Select
  • Cardiovascular-renal-metabolic diseases
  • Computational innovation
  • Eye health
  • Immunology and respiratory diseases
  • Neuroscience
  • Oncology
  • Technology (Antibody)
  • Technology (Small Molecule)

• Tell us more: Required. Provide additional details about your project, like a scientific summary, your interest, and why we may be a good fit to partner.

Consent

Required.

I have read the privacy policy and agree with it. Terms of Use

I hereby confirm that my submission does not contain any confidential information.

Captcha

'I am human', Select in order to trigger the challenge, or to bypass it if you have an accessibility cookie

I am human